Coastwise Capital Group LLC trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 29.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 16,104 shares of the biopharmaceutical company’s stock after selling 6,668 shares during the quarter. Coastwise Capital Group LLC’s holdings […]